ROSEMARY
WANGENSTEEN FUENTES
TITULAR DE UNIVERSIDAD
French Institute of Health and Medical Research
París, FranciaPublicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (1)
2008
-
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins
Journal of Pharmacology and Experimental Therapeutics, Vol. 324, Núm. 2, pp. 539-547